News
27th Mar 2017
NPA spring regionals kick off with focus on antibiotic targets
The NPA’s spring regional meetings kick off this week, giving you the opportunity to make your voice heard on forthcoming antibiotic targets.
27th Mar 2017
Brexit food supply chain coalition calls for EU free trade deal
A coalition of leading food supply chain trade bodies has called on the Government to ensure it secures a two-way tariff-free trade deal with the EU after we leave the union.
23rd Mar 2017
UK pig herd growing, according to December survey
The UK pig herd grew by 3% in 2016, including a 2% increase in the female breeding herd, according to the latest Defra survey figures.
22nd Mar 2017
EU pigmeat exports continue to grow in 2017
Exports of fresh and frozen pork from Europe started 2017 strongly, following a good performance in 2016.
22nd Mar 2017
Lidl makes a commitment to British farming
Discount supermarket Lidl has signed a pledge confirming its commitment to British food and farming.
21st Mar 2017
NPA chief executive updates FSA board on antibiotic progress
NPA chief executive Zoe Davies has updated the Food Standards Agency's (FSA) board on the progress the pig sector is making in reducing antibiotic usage.
21st Mar 2017
Producer share of retail price reaches three-year high
The share of pork retail prices received by producers topped 40% in February, a three-year high, on the back of stable producer prices but falling retail prices.
20th Mar 2017
NPA to work with EU colleagues on 'sensible' zinc oxide transition
The NPA will focus its attention persuading the European Commission to permit a 'sensible' transition period, after the CVMP reiterated its recommendation to ban zinc oxide.
20th Mar 2017
UK slaughterings continue to be well down year-on-year
UK clean pig slaughterings continue to be well down year-on-year, supporting a stable price in the early months of 2017.
17th Mar 2017
EU committee stands by zinc oxide ban recommendation
An EU veterinary committee has reasserted its view that zinc oxide should be banned at therapeutic levels, following a review of its evidence.